Will Stone

Pfizer has submitted data on its bivalent COVID-19 booster shot that specifically targets the latest omicron subvariants. If authorized, the company says the shots could be ready as soon as September.

Missteps and delays have hampered the U.S. effort to vaccinate people against monkeypox. Now state health officials and community members are trying to adapt to a controversial "dose sparing" plan.

Those households are struggling to stay afloat, according to a new poll from NPR, the Robert Wood Johnson Foundation and the Harvard T.H. Chan School of Public Health.

Declaring a public health emergency can free up resources to help the administration respond to the monkeypox outbreak. So far more than 6,000 people in the U.S. have been infected.

Nobody wants to infect their friends and family, but do you really have to keep isolating at day 12, 13 or beyond? Unfortunately — and perhaps unsurprisingly — the science is not entirely settled.

The Biden administration will continue to require travelers to wear masks on planes and other forms of public transport,.

People who get infected with omicron are less likely to go to the hospital, go on a ventilator or die. But with the current huge volume of patients, hospitals are still struggling to treat them all.

The delta variant is pummeling America's hospitals, taxing an already-depleted health care workforce. Once again, some states are facing the prospect of rationing medical care.

A COVID-19 vaccine for children younger than 12 is not yet available, but research is well underway and the first shot for some kids in this age group is expected in the fall, doctors say.

People with weakened immune systems who already got two doses of the Pfizer or Moderna COVID-19 vaccines can now get a third shot. But exactly who is eligible? Here's what we know so far.